Form 4 Filing for Axsome Therapeutics, Inc.

This filing reports a transaction by Roger Jeffs, a director at Axsome Therapeutics, Inc. On June 5, 2026, Mr. Jeffs acquired 1,721 Restricted Stock Units (RSUs) with a transaction value of $0. Each RSU represents a contingent right to one share of the Issuer's common stock. These RSUs are set to vest in full on the one-year anniversary of the grant date. The transaction was filed on June 9, 2026, with the signature of an attorney-in-fact.